Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | BANDHAN Flexi Cap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹104.07 |
| 12 Apr 2015 | ₹192.33 |
| 31 May 2016 | ₹182.07 |
| 19 Jul 2017 | ₹225.56 |
| 07 Sep 2018 | ₹250.63 |
| 27 Oct 2019 | ₹243.44 |
| 15 Dec 2020 | ₹269.32 |
| 03 Feb 2022 | ₹364.86 |
| 25 Mar 2023 | ₹338.12 |
| 12 May 2024 | ₹483.40 |
| 01 Jul 2025 | ₹568.02 |
| 20 Aug 2026 | ₹576.40 |
| Metric | Bandhan · Direct NAV ₹234.14 Very High risk ★★☆☆☆ | Category median Flexi Cap Fund · 46 funds |
|---|---|---|
| +1.51% | +4.32% | |
| +13.30% | +14.11% | |
| +11.67% | +12.53% | |
| +11.42% | +13.78% | |
| +13.71% | +14.48% | |
| +11.07% | — | |
| +14.06% | +16.56% | |
| +13.18% | +15.80% | |
| +13.49% | +15.46% | |
| Risk | ||
| 12.89% | 14.19% | |
| 0.53 | 0.53 | |
| 0.73 | 0.73 | |
| -36.89% | -30.01% | |
| Nifty 500 | — | |
| +1.28% | +2.15% | |
| 0.88 | 0.97 | |
| 95.2% | 102.4% | |
| 86.5% | 90.2% | |
| 1.52% | 0.96% | |
| ₹7,269Cr | ₹4,325Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 14% | 34% | |
| Gaurav Satra | — | |
| 02 Jan 2013 | — | |
| 81 | — | |
| 43.8% | — | |
| 2.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.